Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Polymorphic Variants of TNFR2 Gene in Schizophrenia and Its Interaction with -308G/A TNF-α Gene Polymorphism.

Suchanek-Raif R, Raif P, Kowalczyk M, Paul-Samojedny M, Kucia K, Merk W, Kowalski J.

Mediators Inflamm. 2018 Sep 4;2018:8741249. doi: 10.1155/2018/8741249. eCollection 2018.

2.

TNF signalling via the TNF receptors mediates the effects of exercise on cognition-like behaviours.

Morgan JA, Singhal G, Corrigan F, Jaehne EJ, Jawahar MC, Baune BT.

Behav Brain Res. 2018 Nov 1;353:74-82. doi: 10.1016/j.bbr.2018.06.036. Epub 2018 Jun 30.

PMID:
29969604
3.

A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.

Hoseth EZ, Ueland T, Dieset I, Birnbaum R, Shin JH, Kleinman JE, Hyde TM, Mørch RH, Hope S, Lekva T, Abraityte AJ, Michelsen AE, Melle I, Westlye LT, Ueland T, Djurovic S, Aukrust P, Weinberger DR, Andreassen OA.

Schizophr Bull. 2017 Jul 1;43(4):881-890. doi: 10.1093/schbul/sbw183.

4.

Proteolytic processing of Neuregulin-1.

Willem M.

Brain Res Bull. 2016 Sep;126(Pt 2):178-182. doi: 10.1016/j.brainresbull.2016.07.003. Epub 2016 Jul 5. Review.

PMID:
27393467
5.

The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia.

Turhan L, Batmaz S, Kocbiyik S, Soygur AH.

Nord J Psychiatry. 2016 Jul;70(5):342-50. doi: 10.3109/08039488.2015.1122079. Epub 2016 Jan 12.

PMID:
26754110
6.

Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population.

Yamamori H, Ishima T, Yasuda Y, Fujimoto M, Kudo N, Ohi K, Hashimoto K, Takeda M, Hashimoto R.

Neurosci Lett. 2016 Jan 26;612:167-171. doi: 10.1016/j.neulet.2015.12.019. Epub 2015 Dec 11.

PMID:
26687272
7.

Proinflammatory cytokines and their membrane-bound receptors are altered in the lymphocytes of schizophrenia patients.

Pandey GN, Ren X, Rizavi HS, Zhang H.

Schizophr Res. 2015 May;164(1-3):193-8. doi: 10.1016/j.schres.2015.02.004. Epub 2015 Mar 4.

8.

Inflammatory molecular signature associated with infectious agents in psychosis.

Hayes LN, Severance EG, Leek JT, Gressitt KL, Rohleder C, Coughlin JM, Leweke FM, Yolken RH, Sawa A.

Schizophr Bull. 2014 Sep;40(5):963-72. doi: 10.1093/schbul/sbu052. Epub 2014 Apr 17.

9.

Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia.

Mattei D, Djodari-Irani A, Hadar R, Pelz A, de Cossío LF, Goetz T, Matyash M, Kettenmann H, Winter C, Wolf SA.

Brain Behav Immun. 2014 May;38:175-84. doi: 10.1016/j.bbi.2014.01.019. Epub 2014 Feb 7. Erratum in: Brain Behav Immun. 2015 May;46:328-9.

PMID:
24509090
10.

Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia.

Noto C, Gadelha A, Belangero SI, Spindola LM, Rocha NP, de Miranda AS, Teixeira AL, Cardoso Smith MA, de Jesus Mari J, Bressan RA, Brietzke E.

J Psychiatr Res. 2013 Apr;47(4):467-71. doi: 10.1016/j.jpsychires.2012.12.010. Epub 2013 Jan 26.

PMID:
23360651
11.

Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders.

Dean B, Gibbons AS, Tawadros N, Brooks L, Everall IP, Scarr E.

Mol Psychiatry. 2013 Jul;18(7):767-73. doi: 10.1038/mp.2012.95. Epub 2012 Jul 17.

PMID:
22801413
12.

Association of the Met-196-Arg variation of human tumor necrosis factor receptor 2 (TNFR2) with paranoid schizophrenia.

Thabet S, Ben Nejma M, Zaafrane F, Gaha L, Ben Salem K, Romdhane A, Nour M, Jrad BB.

J Mol Neurosci. 2011 Mar;43(3):358-63. doi: 10.1007/s12031-010-9450-x. Epub 2010 Sep 15.

PMID:
20842464
13.

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor.

Brietzke E, Teixeira AL.

Bipolar Disord. 2010 Jun;12(4):453-4. doi: 10.1111/j.1399-5618.2010.00822.x. No abstract available.

PMID:
20636645
14.

Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency.

Yu B, Becnel J, Zerfaoui M, Rohatgi R, Boulares AH, Nichols CD.

J Pharmacol Exp Ther. 2008 Nov;327(2):316-23. doi: 10.1124/jpet.108.143461. Epub 2008 Aug 15.

PMID:
18708586
15.

Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia.

Coelho FM, Reis HJ, Nicolato R, Romano-Silva MA, Teixeira MM, Bauer ME, Teixeira AL.

Neuroimmunomodulation. 2008;15(2):140-4. doi: 10.1159/000148197. Epub 2008 Aug 5.

PMID:
18679053
16.

Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia.

Bowden NA, Weidenhofer J, Scott RJ, Schall U, Todd J, Michie PT, Tooney PA.

Schizophr Res. 2006 Feb 28;82(2-3):175-83. Epub 2006 Jan 18.

PMID:
16414245
17.

Tumor necrosis factor receptor-II: heritability and effect on brain morphology in schizophrenia.

Wassink TH, Crowe RR, Andreasen NC.

Mol Psychiatry. 2000 Nov;5(6):678-82.

PMID:
11126399

Supplemental Content

Loading ...
Support Center